SCHEMBL27873274

SCHEMBL27873274

CCC(C)C(=O)ONC(=O)c1cccnc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.53
▸ SMN1; SMN2 Q16637 4/20 0.53
▸ TP53 P04637 3/20 0.53
▸ NPC1 O15118 3/20 0.53
▸ RAB9A P51151 3/20 0.53
▸ NPSR1 Q6W5P4 1/20 0.53
▸ KMT2A Q03164 4/20 0.51
▸ MEN1 O00255 3/20 0.51
▸ CYP1A2 P05177 1/20 0.50
▸ CYP3A4 P08684 1/20 0.50
▸ GAA P10253 2/20 0.49
▸ MAPT P10636 1/20 0.49
▸ HDAC1 Q13547 2/20 0.49
▸ THRB P10828 1/20 0.49
▸ HDAC6 Q9UBN7 1/20 0.49
▸ HDAC3 O15379 1/20 0.48
▸ HDAC2 Q92769 1/20 0.48
▸ HPGD P15428 1/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ LMNA P02545 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27367998 0.83 ALDH1A1 (0.54) ALDH1A1SMN1; SMN2NPC1RAB9AKMT2A
SCHEMBL21082071 0.80 HDAC1 (0.54) ALDH1A1SMN1; SMN2TP53NPC1RAB9A
SCHEMBL27889653 0.78 HDAC1 (0.53) ALDH1A1SMN1; SMN2TP53NPC1RAB9A
SCHEMBL9565915 0.77 ALDH1A1 (0.59) ALDH1A1SMN1; SMN2TP53NPC1RAB9A
SCHEMBL30384869 0.77 RAB9A (0.58) ALDH1A1SMN1; SMN2TP53NPC1RAB9A
SCHEMBL13845395 0.76 ALDH1A1 (0.52) ALDH1A1SMN1; SMN2TP53NPC1RAB9A
SCHEMBL30184342 0.76 KMT2A (0.55) ALDH1A1SMN1; SMN2TP53NPC1RAB9A
SCHEMBL27873273 0.76 HDAC1 (0.58) ALDH1A1SMN1; SMN2NPC1RAB9AKMT2A
SCHEMBL24567733 0.76 LMNA (0.67) ALDH1A1SMN1; SMN2TP53NPC1RAB9A
SCHEMBL21467402 0.76 LMNA (0.67) ALDH1A1SMN1; SMN2TP53NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102712595-B Novel compositions for reducing A beta 42 production and their use in treating alzheimer's disease (AD) KAREUS THERAPEUTTICS SA 2015-04-22 — — CN disclosed
CN-102712595-A Novel compositions for reducing A beta 42 production and their use in treating alzheimer's disease (AD) KAREUS THERAPEUTTICS SA 2012-10-03 — — CN disclosed
Send feedback